Netherlands Cancer Institute , Amsterdam, Netherlands
Board Certified Surgical Oncologist, specialized in Melanoma and Soft Tissue Sarcoma.
Started working as Staff Surgeon at Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital (NKI-AVL) from the 1st of January 2015.
Obtained my PhD (cum laude) on the topic of “Sentinel Node (SN) Tumor Load Assessment in Melanoma: Dilemmas and Clinical Management” on January 19th 2011.
Secretary of the EORTC Melanoma Group per 1-1-2015, Early Career Oncologist Member of EORTC Board per 01-2016.
Principal Investigator of the EORTC 1208 (Minitub study). National coordinator of the EORTC 1325 – Keynote 054 (Adjuvant Pembrolizumab vs. Placebo) Study.
Scientific interest mainly now in neo-adjuvant and adjuvant studies for stage III Melanoma (i.e. sub-investigator of OPACIN, OPACIN-NEO and REDUCTOR studies). Also very much involved in setting up and improving ILP and T-VEC programs.
Keywords: Melanoma, Sarcoma, Sentinel Node, SN, Sentinel Lymph Node Biopsy, SLNB, Sentinel Node Procedure, SNP, Sentinel Node Biopsy, SNB, Tumor Burden, Lymph Node Dissection (LND), Completion Lymph Node Dissection (CLND), Surgical Oncology